{"title":"Responsibility Against the Criminal Acts of Medicine Corruption","authors":"Juniaty Simajuntak, Megawati Barthos","doi":"10.4108/eai.16-4-2022.2320098","DOIUrl":null,"url":null,"abstract":". Today, the circulation of counterfeit drugs continues to occur as if it is difficult to stop. As a result of the circulation and use of counterfeit drugs, it will automatically threaten public health. On the other hand, medicines which are the needs of the community, in fact have not been able to be fully affordable by the people who need them considering the price is sometimes not affordable by the community. The problem is, how is the application of accountability to perpetrators of drug counterfeiting crimes? The development of counterfeit drug cases in Indonesia from year to year in terms of the quantity of their distribution is suspected to show an increase. Responding to various public complaints related to the circulation of counterfeit drugs, especially in the Special Capital Region of Jakarta and its surroundings, various legal actions as a form of accountability for perpetrators of drug counterfeiting crimes have been carried out by the ranks of the National Police on a regular basis. The purpose is intended to uncover cases of drug manufacture and distribution of counterfeit drugs which can be categorized as violating \"Anyone who intentionally produces or distributes pharmaceutical preparations and/or medical devices that do not meet standards and/or requirements for safety, efficacy or benefit, and quality as referred to in Article 98 paragraph (2) and paragraph (3) shall be punished with imprisonment for a maximum of 10 (ten) years and a fine of Rp. 1,000,000,000.00 (one billion rupiah), as well as violating Article 196 of Law Number 36 of 2009 concerning Health.\"","PeriodicalId":329533,"journal":{"name":"Proceedings of the 2nd International Conference on Law, Social Science, Economics, and Education, ICLSSEE 2022, 16 April 2022, Semarang, Indonesia","volume":"231 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 2nd International Conference on Law, Social Science, Economics, and Education, ICLSSEE 2022, 16 April 2022, Semarang, Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4108/eai.16-4-2022.2320098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
. Today, the circulation of counterfeit drugs continues to occur as if it is difficult to stop. As a result of the circulation and use of counterfeit drugs, it will automatically threaten public health. On the other hand, medicines which are the needs of the community, in fact have not been able to be fully affordable by the people who need them considering the price is sometimes not affordable by the community. The problem is, how is the application of accountability to perpetrators of drug counterfeiting crimes? The development of counterfeit drug cases in Indonesia from year to year in terms of the quantity of their distribution is suspected to show an increase. Responding to various public complaints related to the circulation of counterfeit drugs, especially in the Special Capital Region of Jakarta and its surroundings, various legal actions as a form of accountability for perpetrators of drug counterfeiting crimes have been carried out by the ranks of the National Police on a regular basis. The purpose is intended to uncover cases of drug manufacture and distribution of counterfeit drugs which can be categorized as violating "Anyone who intentionally produces or distributes pharmaceutical preparations and/or medical devices that do not meet standards and/or requirements for safety, efficacy or benefit, and quality as referred to in Article 98 paragraph (2) and paragraph (3) shall be punished with imprisonment for a maximum of 10 (ten) years and a fine of Rp. 1,000,000,000.00 (one billion rupiah), as well as violating Article 196 of Law Number 36 of 2009 concerning Health."